Quell Therapeutics Granted CTA Approval to Begin First Clinical Trial with a Multi-modular Engineered Treg Cell Therapy

/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), the world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions...

Related Keywords

Boston ,Massachusetts ,United States ,United Kingdom ,London ,City Of ,Frazer Hall ,Iain Mcgill ,Dominik Hartl ,Christina Tartaglia ,Stern Investor Relations Inc ,Prnewswire Quell Therapeutics Ltd ,Regulatory Agency ,Therapeutics Ltd ,Clinical Trial Application ,United Kingdom Medicines ,Chief Medical Officer ,Investor Relations ,Mark Swallow ,Quell Therapeutics ,